|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.736
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.719
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.571
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.527
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.458
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.429
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.424
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.401
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.392
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.389
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.374
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.365
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.358
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.350
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.327
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.296
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.295
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.291
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.276
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.271
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.253
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.251
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.250
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.246
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.244
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.236
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.236
|
|
|
|
leukocyte cell cell adhesion
|
GO:0007159 |
14 |
0.223
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.223
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.222
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.218
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.218
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.210
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.208
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.206
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.205
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.205
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.203
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.202
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.196
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.192
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.186
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.180
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.179
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.178
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.178
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.171
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.171
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.171
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.170
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.170
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.169
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.169
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.168
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.165
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.162
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.161
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.159
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.157
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.154
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.153
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.153
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.152
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.152
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.152
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.149
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.149
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.148
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.146
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.146
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.146
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.145
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.143
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.142
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.137
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.136
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.134
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.132
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.130
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.129
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.129
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.127
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.127
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.124
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.123
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.120
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.119
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.118
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.117
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.115
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.114
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.113
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.110
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.110
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.110
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.110
|
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.109
|
|
|
|
positive regulation of semaphorin plexin signaling pathway
|
GO:2001262 |
1 |
0.108
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.107
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.105
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.103
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.102
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.101
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.101
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.098
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.097
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.096
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.096
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.096
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.095
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.094
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.093
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.093
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.092
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.091
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.091
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.090
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.089
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.089
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.088
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.087
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.087
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.087
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.086
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.086
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.084
|
|
|
|
positive regulation of mechanoreceptor differentiation
|
GO:0045633 |
1 |
0.084
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.084
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.084
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.082
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.080
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.078
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.077
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.076
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.075
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.075
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.074
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.074
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.073
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.073
|
|
|
|
positive regulation of exit from mitosis
|
GO:0031536 |
1 |
0.073
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.072
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.071
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.071
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.071
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.070
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.070
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.070
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.069
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.069
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.069
|
|
|
|
axonal fasciculation
|
GO:0007413 |
15 |
0.068
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.067
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.067
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.067
|
|
|
|
regulation of arp2 3 complex mediated actin nucleation
|
GO:0034315 |
1 |
0.066
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.066
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.066
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.066
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.066
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.065
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.065
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.064
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.063
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.063
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.062
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.062
|
|
|
|
epidermal growth factor receptor signaling pathway via i kappab kinase nf kappab cascade
|
GO:0038168 |
1 |
0.061
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.061
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.061
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.061
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.060
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.060
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.060
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.060
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.059
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.059
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.059
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.059
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.058
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.058
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.058
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.057
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.056
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.056
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.056
|
|
|
|
megakaryocyte development
|
GO:0035855 |
15 |
0.056
|
|
|
|
semaphorin plexin signaling pathway
|
GO:0071526 |
21 |
0.055
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.055
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.055
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.055
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.054
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.054
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.053
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.053
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.053
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.053
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.053
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.053
|
|
|
|
intracellular distribution of mitochondria
|
GO:0048312 |
1 |
0.053
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.052
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.052
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.051
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.051
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.051
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.051
|
|
|
|
adherens junction organization
|
GO:0034332 |
28 |
0.051
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.051
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.050
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.050
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.050
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.050
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.049
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.049
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.049
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.049
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.049
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.049
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.049
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.049
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.048
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.048
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.048
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.048
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.048
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.048
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.047
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.047
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.047
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.047
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.047
|
|
|
|
regulation of multicellular organismal metabolic process
|
GO:0044246 |
14 |
0.047
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.047
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.047
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.046
|
|
|
|
hydrogen transport
|
GO:0006818 |
35 |
0.046
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.046
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.046
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.046
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.046
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.046
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.045
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.045
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.045
|
|
|
|
immune response regulating cell surface receptor signaling pathway involved in phagocytosis
|
GO:0002433 |
1 |
0.045
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.045
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.045
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.045
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.045
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.044
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.044
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.044
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.044
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.044
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.044
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.044
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.044
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.044
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.044
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.044
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.044
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.043
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.043
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.043
|
|
|
|
deltoid tuberosity development
|
GO:0035993 |
3 |
0.042
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.042
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.042
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.042
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.042
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.042
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.042
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.042
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.041
|
|
|
|
negative regulation of oxidative phosphorylation uncoupler activity
|
GO:2000276 |
2 |
0.041
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.041
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.041
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.041
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.041
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.041
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.040
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.040
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.040
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.040
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.040
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.039
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.039
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.039
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.039
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.039
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.039
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.038
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.038
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.038
|
|
|
|
mast cell activation involved in immune response
|
GO:0002279 |
20 |
0.038
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.038
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.037
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.037
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.037
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.037
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.037
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.037
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.037
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.037
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.037
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.037
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.037
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.037
|
|
|
|
positive regulation of calcium mediated signaling
|
GO:0050850 |
15 |
0.036
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.036
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.036
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.036
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.036
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.036
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.036
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.036
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.035
|
|
|
|
embryonic olfactory bulb interneuron precursor migration
|
GO:0021831 |
2 |
0.035
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.035
|
|
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.035
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.035
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.035
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.035
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.034
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.034
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.034
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.034
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.034
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.034
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.034
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.033
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.033
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.033
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.033
|
|
|
|
proton transport
|
GO:0015992 |
35 |
0.033
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.033
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.033
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.033
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.033
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.033
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.033
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.032
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.032
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.032
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.032
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.032
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.032
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.032
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.032
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.032
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.032
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.032
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.032
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.031
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.031
|
|
|
|
regulation of stem cell maintenance
|
GO:2000036 |
17 |
0.031
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.031
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.031
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.031
|
|
|
|
t cell selection
|
GO:0045058 |
34 |
0.031
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.031
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.031
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.031
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.030
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.030
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.030
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.030
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.030
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.030
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.030
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.030
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.030
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.030
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.029
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.029
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.029
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.029
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.029
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.028
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.028
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.028
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.028
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.028
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.028
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.028
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.028
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.028
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.027
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.027
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.027
|
|
|
|
learning
|
GO:0007612 |
98 |
0.027
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.027
|
|
|
|
establishment of glial blood brain barrier
|
GO:0060857 |
2 |
0.027
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.027
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.027
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.026
|
|
|
|
germinal center formation
|
GO:0002467 |
16 |
0.026
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.026
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.026
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.026
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.026
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.026
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.026
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.026
|
|
|
|
tolerance induction to self antigen
|
GO:0002513 |
4 |
0.026
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.026
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.025
|
|
|
|
arp2 3 complex mediated actin nucleation
|
GO:0034314 |
3 |
0.025
|
|
|
|
interleukin 4 production
|
GO:0032633 |
24 |
0.025
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.025
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.025
|
|
|
|
activation of rac gtpase activity
|
GO:0032863 |
2 |
0.025
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.025
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.025
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.025
|
|
|
|
regulation of actin nucleation
|
GO:0051125 |
4 |
0.025
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.025
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.025
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.025
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.025
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.024
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.024
|
|
|
|
face development
|
GO:0060324 |
38 |
0.024
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.024
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.024
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.024
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.024
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.024
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.024
|
|
|
|
cell substrate adherens junction assembly
|
GO:0007045 |
19 |
0.024
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.024
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.023
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.023
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.023
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.023
|
|
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.023
|
|
|
|
cellular response to ethanol
|
GO:0071361 |
3 |
0.023
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.023
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.023
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.023
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.023
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.023
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.023
|
|
|
|
establishment of monopolar cell polarity
|
GO:0061162 |
8 |
0.023
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.023
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.023
|
|
|
|
tongue development
|
GO:0043586 |
18 |
0.023
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.023
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.022
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.022
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.022
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.022
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.022
|
|
|
|
regulation of organ formation
|
GO:0003156 |
34 |
0.022
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.022
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.022
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.022
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.022
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.022
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.022
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.022
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.022
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.022
|
|
|
|
negative regulation of peroxisome proliferator activated receptor signaling pathway
|
GO:0035359 |
3 |
0.022
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.022
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.022
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.021
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.021
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.021
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.021
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.021
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.021
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.021
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.021
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.021
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.021
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.021
|
|
|
|
cd4 positive alpha beta t cell differentiation involved in immune response
|
GO:0002294 |
28 |
0.021
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.021
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.021
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.021
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.021
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.021
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.021
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.021
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.021
|
|
|
|
hair cell differentiation
|
GO:0035315 |
40 |
0.021
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
23 |
0.021
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.021
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.021
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.020
|
|
